We say goodbye to a historic year, marked by unprecedented difficulties in medical, economical, political and of course, in pure human terms. With hard work and effective oganization, in this difficul
Tchaikapharma High Quality Medicines Inc. remains the most expensive Bulgarian company on the Bulgarian Stock Exchange. After the market capitalization of the pharmaceutical company exceeded BGN 1 bil
Patients with rheumatic disease are less likely to suffer from coronavirus, especially those taking hydroxychloroquine. That is why their therapy should not be interrupted during the pandemic, says rh
Tchaikapharma High Quality Medicines retains its position as the most expensive Bulgarian company on the BSE. After the players on the stock exchange estimated the pharmaceutical company at BGN 1,027,
There is a company on the Bulgarian Stock Exchange with a value of over a billion leva, according to data in the bulletin of the stock exchange operator for the second quarter. This is Tchaikapharma H
Briefing at the Ministry of health
Global COVID-19 prevention trial of hydroxychloroquine to resume LONDON (Reuters) – A global trial designed to test whether the anti-malaria drugs hydroxychloroquine and chloroquine can prevent
MoriVid (hydroxychloroquine sulfate) 200 mg, 30 tablets, expected by thousands of Bulgarian patients, is now available in the pharmacies countrywide. The distributor of the medicinal product is Commer
Prof. Toni Vekov – Director of the scientific board of Tchaikapharma, prof. Rasho Rashkov – Chairman of the Bulgarian Rheumatology Society and Boryana Boteva – Chairman of the Rheumatology Patients Or
(updated on 5 June, 14:30 ) In response to numerous inquiries from doctors, journalists and especially from patients suffering from autoimmune diseases, we confirm inform that Tchaikapharma High Quali
Tchaikapharma High Quality Medicines AD (BSE: 7TH) intends to build a third manufacturing plant in the village of Kazichene near Sofia. This became clear from documents published in the Commercial Reg
President Trump takes hydroxychloroquine to prevent coronavirus infection even though it’s an unproven treatment Professor Toni Vekov in an interview with NOVA: Tchaikapharma R&D Team worked aroun
Within a couple of days, Tchaikapharma is about to produce the first 5,000 MoriVir (hydroxychloroquin) packs for the front-line hospitals in the battle against COVID-19, and in May, another 20,000 Gra
Tchaikapharma High Quality Medicines received a thank-you letter from Prof. Diana Ivanova, Ph.D., Dean of the Pharmacy Faculty at the Varna Medical University in connection with the “empathy and
In 2019 Tchaikapharma (BSE:7TH) affirmed its leadership through successful development of scientific projects based on the advanced research on the development and integration of innovative combo medi
Numerous spectators attended the traditional restoration of the Battle of Slivnitsa. Many volunteers were involved in the recreation of the events of the Serbo-Bulgarian War of 1885. This year again,
Bulgaria’s Young Talents in The Field of Synthetic Biology Expressed Their Gratitude for The Support Provided Tchaikapharma High Quality Medicines Ltd. supports Bulgaria’s Team of Synthetic Biology yo
Tchaikapharma High Quality Medicines ranks among the leaders in the Prescription Drugs (Rx) market for the past 12 months (as of June 2019). The ranking “Top 10 Corporations in the market for prescrip
By the end of 2018, Tchaikapharma expects to be issued with Marketing Authorizations for three new prescription drugs, which will enrich the portfolio and the well-developed therapeutic baskets of the
Tchaikapharma completed the bioequivalence clinical trials of 4 new dual-component pharmaceutical products for the treatment of arterial hypertension and other cardiovascular diseases – with sucsess.
Pizona Combi contains pioglitazone and metformin that controls blood sugar levels. It helps the body to utilize better produced by body insulin when metformin alone is insufficient. The medicinal prod
The 33rd National Meeting of the Association of Medical Students in Bulgaria was held in Pleven from 16 to 18 March with the support of Tchaikapharma. A specially designed booth will welcome the parti
Tchaikapharma has won award in the category of solution providers during the Pharm Connect congress which is the most notable meeting of leading pharmaceutical and biotechnology companies for Central
The newest addition to Tchaikapharma High Quality Medicines Inc. product list is Ivabenor 5 mg and 7,5 mg film-coated tablets. The cardiological medicinal product contains the active substance ivabrad
Tchaikapharma High Quality Medicines Available for All wishes you a Happy Easter!
Interview with the production manager at Tchaikapharma’s plant in Plovdiv – Vasil Pavlov. The requirements for the production of medicinal products resulting from the GMP (good manufacturing pr
Tchaikapharma High Quality Medicines has been the first choice of Bulgarian doctors for 18 years.
Tchaikapharma High Quality Medicines Inc. received another Marketing Authorization by the Bulgarian Drug Agency with which the company updated its list of injectable products. The new oncological drug
Bortezomib-Tchaikapharma 3.5 mg powder for solution for injection is Tchaikapharma High Quality Medicines’ newest medicinal product which obtained a Marketing Authorisation by the Bulgarian Drug Agenc
Lidocaine-Tchaikapharma 10 mg and 20 mg solution for injection is Tchaikapharma’s newest product which has obtained a Marketing Authorization issued by the Bulgarian Drug Agency. Therapeutic indicatio
The renowned business ranking “300 Business Leaders in Bulgaria” for one more year honoured Tchaikapharma High Quality Medicines Inc. as one of the most profitable and influential companie
The newest product of Tchaikapharma High Quality Medicines Inc., which BDA gave a marketing authorisation for, is Cilapenem 500 mg/500 mg powder for infusion solution. Each phial contains the followin
The newest medicinal product placed on the market after having received a marketing authorization from the Bulgarian Drug Agency by the Ministry of Health is the infusion solution Linezolid-Tchaikapha
On the Bulgarian pharmaceutical market the latest addition to constantly growing product list of Tchaikapharma High Quality Medicines Inc. for the treatment of cardiovascular diseases is offered from
After successfully completing the third for the company Decentralised Procedure (DCP) Tchaikapharma High Quality Medicines Inc. received Marketing Authorisation for the medicinal product Tamayra 5 mg/
Tchaikapharma High Quality Medicines Inc. was granted Marketing Authorisations for the medicinal products Ibodria 6 mg/6 ml concentrate for solution for infusion and Ibodria 3 mg/3 ml solution for inj
The Bulgarian Pharmaceutical Union awarded Tchaikapharma High Quality Medicines Inc. for cardiological medicinal product Amariton in the category “Medicinal Product Subject to Medicinal Prescription –
Tchaikapharma High Quality Medicines Inc. was granted Marketing Authorisations for the medicinal products Atorva 40 mg and 80 mg film-coated tablets. Each tablet contains the active substance atorvast
On 10/05/2016, the BDA successfully completed within the specified period the first decentralised procedure (DCP) for marketing authorisation of medicinal products for which Bulgaria is the Reference
Dear Colleagues, Happy Holidays! Your everyday efforts to improve people’s health and save people’s lives are and have always been worthy of respect! All impediments we face with combine
This year again, employees of Commercial League assumed the role of Santa Claus and delighted the kids from Konstantsa Lyapcheva orphanage in the town of Dolna Banya. More than 20 children were asked
Tchaikapharma High Quality Medicines Inc. was distinguished among the most profitable and influential companies in Bulgaria for the 2014 business rating “300 Business leaders in Bulgaria”. In this yea
The National Health Service in the UK discontinues the coverage of 25 cancer drugs Twenty five drugs that each year give a last chance to patients with cancer – including breast, prostate and co
The participants in the National Round Table on Reforms and Healthcare without Restrictions insist that the government restores the principle “the funding follows the patient” “We do
The specialized hospitals of the Bulgarian Cardiac Institute in Varna, Veliko Tarnovo, Shumen and Yambol mark the World Heart Day with an appeal for prevention and free consultations Every year on the
For the first time clinical trials will be conducted to check if a drug prolonged life, said magazine Sciences et Avenir. The medicine in question is metformin, which is often administered to patient
According to Minister Moskov, when one has a facility in the big city where people have assets, one has to take responsibility for the system as well. According to the guild, the solution is to permit
Doctors specializing in Medicine will have a right to a contract with the NHIF was decided by the MPs yesterday, when they accepted the amendments to the Law on Medical Institutions. This way they mad
The Health Insurance Fund will finance hospitals only according to the needs of the population The Health Insurance Fund will not finance all newfound hospitals and will base its decisions on the Nati
For the first time the Republic of Bulgaria, as a Member State of the EU, will be the reference country in the decentralized procedure (DCP) for Marketing Authorisation for a medicinal products with a
Bulgarian Drug Agency issued a new Marketing Authorisation to Tchaikapharma High Quality Medicines Inc. for the medicinal product for treatment of diabetes mellitus Aroba 100 mg tablets. Aroba contain
The Guardian wrote that the Scientists had found that two licensed drugs stopped the degeneration of the brain in mice. The discovery gives hope of success in the search for drugs for the therapy of A
Prof. Marita Eisenmann predicted that after 10 years the fat grifting method will completely replace breast implants. Three women after mammectomy due to breast cancer undergo reconstructive surgery t
There are reported cases of serious, sometimes life-threatening cases of diabetic ketoacidosis in patients with type 2 diabetes treated with SGLT2-inhibitors. This is reported by the manufacturers aft
During the past 2014 the NHIF allocated 72 million for rare medicines The innovations are crucial for achieving better treatment, but they are very expensive. Good examples of this are the so called “
A new front in the National Assembly against the reduced requirements for managers was formed. The Health Minister Petar Moskov has proposed a liberalization of the requirements for managers in the Me
The results of a retrospective study published in the Journal of the American College of Cardiology show that the patients with critical limb ischemia who took statins had a significantly lower incide
At the press conference some days ago the Minister of Health Dr. Peter Moskov stated that at that time the valuation of clinical pathways was like a cat in a bag – no one knew what was in it. He
The first health reforms initiated by the government are already happening. With the support of the deputies from the parties Patriotic Front and Alternative for Bulgarian Revival last week were adopt
Metformin is the most commonly used anti-diabetic medicine worldwide. It is generally recognized by experts as the first choice diabetic glucose-lowering drug for glycemic diabetes type 2 (DT2) contro
Nebivolol is a third generation beta-adrenergic receptor blocker with vasodilating properties. It has the highest affinity for beta-1 receptors when compared to other beta-blockers (BB). Due to the le
June 14, 2015 marks the 10th anniversary from the creation of the Department of Cardiac Surgery at the University Hospital “St. Marina” at the Medical University in Varna “Prof. Dr. Parask
The rating system for assessing of the employers is part of a joint project of the CITUB and the Bulgarian Industrial Association. Tchaikapharma High Quality medicines Inc. is rated second in one of t
Tchaikapharma High Quality Medicines Inc. received Marketing Authorization for Pizona – a new medicine for diabetes. Tchaikapharma High Quality Medicines Inc. received new Marketing Authorization for
The team of “Tchaikapharma High Quality Medicines” wishes you warm and happy Christmas and New Year holidays!
Interview with Nikolay Hadjidonchev, Chairman of the Bulgarian Generic Pharmaceutical Association “BGPharmA” For two years you are fighting to get a precise breakdown of costs for medicines by the hea
The situation with the private Cardiology Hospital in Vidin should be recorded in textbooks as an example of how power is misused without punishment – Dr. Katzarov how is power (mis)used without
Three hospitals refused to admit for treatment a 47 year-old woman from Kazanlak with acute myocardial infarction. After a whole day of wandering between health facilities Dafinka Boneva was hospitali
After a 10-month delay the state prosecution paid BGN 100 000 compensation to the three doctors charged in the death of 5-month-old Maria in Pazardzhik hospital seven years ago. Then the child died of
Comments by Dr. Stojcho Katzarov, Chairman of the Board of Directors of the Center for Protection of Healthcare Rights. People say: Hospitals are commercial entities and this interferes with medical c
At a meeting held last week the government approved amendments to the Regulation on calculation and payment of cash compensation and benefits from public social security related to the introduction fr
The Agreement for cooperation for implementation of effective control over the funds in the field of interventional cardiology and cardiac surgery, was signed last week. The press center of the Fund a
Today, with a charity campaign in favor of the Fund for treatment of children the Bulgarian Medical Association commemorates the Day of the Bulgarian physician. On October 19, the holiday of St. Ivan
The BMA wants the physicians to have guaranteed treatment for infections acquired in the workplace. This was announced by the Professional Association during the Congress of Nephrology in Hissar. The
There are no problems with the regulatory standards provided for the last quarter of the year. This was announced by the press center of the NHIF in connection with the emerging information that the r
Assoc. Prof. Dr. Sotir Marchev, MD, was born in 1961 in Blagoevgrad. He graduated with a gold medal from English High School, and then, also with honors, the Medical University in Sofia. He has two sp
People want control over the health care system, but do not bother to carry it out in person, even if such an opportunity is provided to them. This becomes evident from the report of the NHIF of the i
The Health Ministry will purchase almost 40 000 vaccines for a total amount of BGN 4.27 million without a tender, through direct negotiation procedure. The aim is to control the crisis with the 6-vale
Among them are some of the best-selling medications for pain, flu and allergies. The result of the imposed antimarket one year moratorium on the increase of prices of the over-the-counter medicines is
All staff working in hospital pharmacies must have an employment contract with the recpective medical facility which opened the pharmacy. This is provided in the draft amendment to the Ordinance No.28
Community-acquired pneumonia (CAP) is a common infectious disease of the lungs that occurs with significant morbidity and mortality. In Europe and America about 4 million cases of CAP lead to 1 millio
The elderly people in our country are satisfied with the General Practitioners and pharmacists, because they in details and clearly explain them the diseases and drug therapies and are considerate and
Vyara Vragova of the patient organization “Type 2 diabetes” said that the General Practitioners neglect the problem of type 2 diabetes. According to her the General Practitioners “do not pay much atte
The National Health Insurance Fund announced that on the last day of September National it received the funds for this July needed to pay the difference in user fee for pensioners to general practitio
The employers and the trade unions supported the revised budget of the NHIF proposed by the interim government. The social partners, however, strongly objected against the situation in health care, st
The Gerneral Practitioners can, without problems, report to the NHIF the Immunizations preformed in children despite the changes of the terms of their performance There are no problems for the General
Levofloxacin monotherapy is highly effective in community-acquired pneumonia Levofloxacin is one of the three respiratory fluoroquinolones that are recommended for empirical treatment of a wide range
Mr. Georgi Georgiev, Chairman, Town Council of Slivnitsa Municipality, greeted Prof. Mladen Grigorov, Chairman of the Bulgarian Monuments of Glory Foundation and Prof. Toni Vekov, Member of the Counci
Tchaikapharma High Quality Medicines Inc. was acknowledged for a consecutive time for its contribution to the development of the pharmaceutical sector in Bulgaria. The Chairman of the Bulgarian Pharma
For the sixth consecutive year the Bulgarian Pharmaceutical Union held the Bulgarian Pharmaceutical Days under the motto “Equal Access to Medicines and Pharmaceutical care”. The event was attended by
This content is currently not available in English.
The public stance of Tchaikapharma High Quality Medicines regarding the reimbursement and pharmaceutical policy, effective since 2004 June 10, 2010 In Bulgaria t
The newest addition to Tchaikapharma High Quality Medicines Inc. prescription drugs (Rx) product list are the following: – Zornichka (chlorthalidone) – for the treatment of arterial hyper
In the last nine years Tchaikapharma High Quality Medicines Affordable for Everyone has earned its reputation as one of the main Bulgarian pharmaceutical manufacturers with the fastest development rat
[:en]Patients who take the antipsychotic drug clozapine risk a group of health conditions called metabolic syndrome, researchers warn. Metabolic syndrome's cluster of obesity, high blood glucose level
[:en] High humidity can increase the risk of a heart attack in the elderly even in relatively mild climates, according to the study “Climate Impacts on Myocardial infarction deaths in the Athens Terri